Research Advances of Adiponectin in Metabolic Syndrome and Cardiovascular Disease
Author:
  • Article
  • | |
  • Metrics
  • | | | | |
  • Comments
    Abstract:

    Adiponectin (APN) is secreted from adipose tissue and contributed to the important protective effects in metabolic syndrome and cardiovascular disease. Level of APN is markedly reduced in patients with obesity,diabetes,hypertension,and coronary artery disease. APN exerts the effects of increasing insulin sensitivity,anti-inflammation,anti-atherosclerosis and protecting myocardium. This review will focus on functions involved in APN and its receptors in diabetes,insulin resistance,metabolic syndrome,cardiovascular disease.

    Reference
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

GUO Ying-Ying, BIAN Yun-Fei, and XIAO Chuan-Shi. Research Advances of Adiponectin in Metabolic Syndrome and Cardiovascular Disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2015,23(05):527-531.

Copy
Share
Article Metrics
  • Abstract:1354
  • PDF: 1947
  • HTML: 0
  • Cited by: 0
History
  • Received:October 08,2014
Article QR Code